Skip to main content
TipRanks
Go Ultimate75% OFF

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Income Statement

3 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Income Statement

Last quarter (Q2 2026), ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's total revenue was ¥37.25M, an increase of 5075.31% from the same quarter last year. In Q2, ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's net income was ¥-164.19M. See ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 150.30M¥ 74.15M¥ 386.00K¥ 5.69M¥ 13.81M
¥ 134.99M¥ 74.15M¥ 7.70M¥ 5.69M¥ 13.81M
¥ 352.25M¥ 382.19M¥ 372.37M¥ 370.14M¥ 224.27M
Depreciation and Amortization¥ 14.23M¥ 20.68M¥ 22.58M¥ 17.62M¥ 13.18M
¥ -203.03M¥ -287.36M¥ -355.35M¥ -384.49M¥ -718.88M
¥ -217.26M¥ -308.04M¥ -364.67M¥ -364.45M¥ -210.47M
¥ 3.68M¥ -8.55M¥ -14.79M¥ -38.44M¥ -522.48M
¥ -213.58M¥ -316.59M¥ -379.46M¥ -402.89M¥ -732.95M
¥ -212.92M¥ -315.86M¥ -379.46M¥ -402.89M¥ -732.95M
Per Share Metrics
Basic EPS¥ -0.51¥ -0.84¥ -1.05¥ -1.08¥ -1.96
Diluted EPS¥ -0.51¥ -0.84¥ -1.05¥ -1.08¥ -1.96
Weighted Average Shares Outstanding412.44M377.15M361.81M373.24M373.24M
Weighted Average Shares Outstanding (Diluted)412.44M377.15M361.81M373.24M373.24M

Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Earnings and Revenue History

-800M-400M0400M-120000 %-80000 %-40000 %0 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin